Cytosolic phospholipase A2? blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples